Should SGLT2i be used prior to transcatheter edge‐to‐edge repair for secondary mitral regurgitation?
Author:
Affiliation:
1. Department of Medicine David Geffen School of Medicine at UCLA Los Angeles California USA
2. Division of Cardiology David Geffen School of Medicine at UCLA Los Angeles California USA
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23603
Reference8 articles.
1. ACC/AHA guideline for the management of patients with valvular heart disease;Otto Catherine M;J Am Coll Cardiol,2020
2. Transcatheter Mitral-Valve Repair in Patients with Heart Failure
3. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
4. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
5. Randomized trial of empagliflozin in non‐diabetic patients with heart failure and reduced ejection fraction;Santos‐Gallego CG;J Am Coll Cardiol,2020
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined Pharmacological and Complex and High-risk Coronary Intervention of Chronic Total Occlusion for Ischemic Mitral Regurgitation;Indian Journal of Clinical Cardiology;2022-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3